Understanding OUR Cytokine-Based Immunotherapy Candidates Our Commitment extends to advancing a robust portfolio of programs aimed at growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy solutions remain limited. Make use of the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Explore https://financefeeds.com/tether-to-acquire-majority-stake-in-agribusiness-adecoagro/